Company intelligence / Profile preview

Overleaf

Ownership: Private
Employees: ~80
Development stage: Other

Overview

Overleaf is a cloud-based, collaborative LaTeX editor used primarily for scientific writing and publishing. It provides a real-time environment for researchers to write, edit, and share their work, featuring integrated version control and a wide range of journal templates. While not a biotechnology company itself, Overleaf is a critical infrastructure provider for the life sciences and healthcare research communities, facilitating the documentation and dissemination of scientific discoveries. The platform is used by millions of researchers across academia and industry to streamline the publication process.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

IEEESpringer NatureOxford University PressCambridge University Press

Beyond the preview

Go deeper on Overleaf.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Overleaf.

Explore the full profile